U.S. Markets open in 5 hrs 7 mins
  • S&P Futures

    4,196.00
    +1.75 (+0.04%)
     
  • Dow Futures

    34,448.00
    +6.00 (+0.02%)
     
  • Nasdaq Futures

    13,607.25
    +9.50 (+0.07%)
     
  • Russell 2000 Futures

    2,242.20
    +2.30 (+0.10%)
     
  • Crude Oil

    64.68
    -0.03 (-0.05%)
     
  • Gold

    1,819.90
    +4.20 (+0.23%)
     
  • Silver

    27.43
    -0.03 (-0.10%)
     
  • EUR/USD

    1.2079
    +0.0010 (+0.0846%)
     
  • 10-Yr Bond

    1.5610
    0.0000 (0.00%)
     
  • Vix

    18.44
    -0.71 (-3.71%)
     
  • GBP/USD

    1.3927
    +0.0035 (+0.2493%)
     
  • USD/JPY

    109.1520
    +0.0670 (+0.0614%)
     
  • BTC-USD

    55,739.26
    -1,215.38 (-2.13%)
     
  • CMC Crypto 200

    1,454.10
    -17.32 (-1.18%)
     
  • FTSE 100

    7,103.36
    +27.19 (+0.38%)
     
  • Nikkei 225

    29,357.82
    +26.45 (+0.09%)
     

Renalytix AI (RNLX) Catches Eye: Stock Jumps 7%

  • Oops!
    Something went wrong.
    Please try again later.
Zacks Equity Research
·2 min read
  • Oops!
    Something went wrong.
    Please try again later.

Renalytix AI plc RNLX was a big mover last session, as the company saw its shares rise nearly 7% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend for the company—as the stock is now up 40.8% in the past one-month time frame.

This move came after Renalytix AI announced its partnership with healthcare company DaVita for a first-of-its-kind program which will help adults with chronic kidney disease to improve health outcomes and slow down the progression of the said disease.

The company has seen no changes when it comes to estimate revision over the past few weeks, while the Zacks Consensus Estimate for the current quarter has also remained unchanged. The recent price action is encouraging though, so make sure to keep a close watch on this firm in the near future.
 

Renalytix AI PLC Sponsored ADR Price

Renalytix AI PLC Sponsored ADR Price
Renalytix AI PLC Sponsored ADR Price

Renalytix AI PLC Sponsored ADR price | Renalytix AI PLC Sponsored ADR Quote

Renalytix AI currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.  

A better-ranked stock in the Computers - IT Services industry is Dell Technologies Inc. DELL, which currently carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Dell Technologies Inc. (DELL) : Free Stock Analysis Report
 
Renalytix AI PLC Sponsored ADR (RNLX) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research